SlideShare a Scribd company logo
1 of 17
XENOTRANSPLANTATION
CONCEPT

Xenotransplantation is
the transplantation of
cells, tissues or organs
from one species to
another,      particularly
transplants from animals
to humans.

It was formulated to
overcome the shortage
of donor organs.
HISTORY
TYPES OF XENOTRANSPLANTATION
               SOLID
               ORGAN
              XENOTRA
              NSPLANT




                          CELLULAR
    HUMAN/A
                           /TISSUE
     NIMAL     TYPES      XENOTRA
     HYBRID
                          NSPLANT




              EXTERNAL
              THERAPIES
CHOOSING THE DONOR SPECIES
TYPE         BETWEEN EXAMPLE


CONCORDANT   Closely
             related/si   Baboon     Human
             milar
             species




DISCORDANT   Distantly
             related/          Pig     Human
             dissimilar
             species
TRANSPLANTATION
REJECTION;IMMUNOLOGICAL
        BARRIERS

   1.Hyperacute xenograft rejection,HXR


         2.Cellular xenograft rejection,


    3.Acute vascular xenograft rejection,ACXR



        4.Chronic xenograft rejection,
1.Hyperacute xenograft rejection,HXR
OVERCOMING HYPERACUTE REJECTION




•alter the organ source through using genetically engineered
pigs (e.g., pigs that will lack the α-Gal epitope and/or will have
an artificially added gene[s] for human complement-regulatory
proteins (such as decay-accelerating factor)

• alter the recipient by depleting naturally occurring
antibodies directed against α-Gal (NXAs) prior to xenograft
receipt. Either approach to overcoming HAR may also
facilitate the potential for the human recipient to be infected
by endogenous retroviruses from the pig xenotransplantation
product.
2.Acute vascular xenograft rejection,ACXR
OVERCOMING ACUTE VASCULAR REJECTION




•Administering a synthetic thrombin inhibitor to modulate
thrombogenesis

•Depletion of anti-galactose antibodies (XNAs) by
techniques such as immunoadsorption, to prevent
endothelial cell activation

•Inhibiting activation of macrophages (stimulated by
CD4+ T cells) and NK cells (stimulated by the release of
Il-2). Thus, the role of MHC molecules and T cell
responses in activation would have to be reassessed for
each species combo.
3.Cellular xenograft rejection,
A proposed strategy to avoid cellular rejection is to induce donor
non-responsiveness using hematopoietic chimerism. Donor stem
cells are introduced into the bone marrow of the recipient, where
they coexist with the recipient’s stem cells. The bone marrow stem
cells give rise to cells of all hematopoietic lineages, through the
process of hematopoiesis. Lymphoid progenitor cells are created by
this process and move to the thymus where negative selection
eliminates T cells found to be reactive to self. The existence of
donor stem cells in the recipient’s bone marrow causes donor
reactive T cells to be considered self and undergo apoptosis.
4.Chronic xenograft rejection,
One concern raised about xenotransplantation
    is the risk of inadvertent transmission of
infectious agents into xenotransplant recipients
    and subsequent secondary transmission of
 infections to the wider human population. This
 risk is an important obstacle to the use of this
     technology. The potential for secondary
  transmission of infections makes the risk of
            xenozoonoses a global issue.




  XENOZOONOTIC DISEASE RISK AND PREVENTION ISSUES
"O Adam! shall I lead thee to the
 Tree of Eternity and to a kingship
that never decays?" (20:120). Satan
also said "I will mislead them, and I
 will create in them false desires; I
      will order them to have (in
  abundance) the animals' ears cut
 (from the origin), and I will order
  them to change Allah's creation"
                (4:119).
THANK YOU !

More Related Content

What's hot

Xenorenotransoplantation 1
Xenorenotransoplantation 1Xenorenotransoplantation 1
Xenorenotransoplantation 1
Vishal Ramteke
 
Transgenic animals
Transgenic animals Transgenic animals
Transgenic animals
MSCW Mysore
 

What's hot (20)

Xenorenotransoplantation 1
Xenorenotransoplantation 1Xenorenotransoplantation 1
Xenorenotransoplantation 1
 
Transgenic animals
Transgenic animalsTransgenic animals
Transgenic animals
 
Primary culture and cell line
Primary culture and cell linePrimary culture and cell line
Primary culture and cell line
 
Animal cell culture media
Animal cell culture mediaAnimal cell culture media
Animal cell culture media
 
Transgenic animals
Transgenic animals Transgenic animals
Transgenic animals
 
Animal cloning
Animal cloningAnimal cloning
Animal cloning
 
Cell culture based vaccine
Cell culture based vaccineCell culture based vaccine
Cell culture based vaccine
 
Transgenic Animals
Transgenic AnimalsTransgenic Animals
Transgenic Animals
 
Cell culture media
Cell culture mediaCell culture media
Cell culture media
 
Transgenesis in animals
Transgenesis in animalsTransgenesis in animals
Transgenesis in animals
 
Micromanipulation.pptx
Micromanipulation.pptxMicromanipulation.pptx
Micromanipulation.pptx
 
Therapeutic cloning
Therapeutic cloningTherapeutic cloning
Therapeutic cloning
 
STEM CELL CULTURE
STEM CELL CULTURE STEM CELL CULTURE
STEM CELL CULTURE
 
Transgenic animals ppt
Transgenic animals pptTransgenic animals ppt
Transgenic animals ppt
 
Gene knockout
Gene knockoutGene knockout
Gene knockout
 
Constituent of animal tissue culture media and their specific application
Constituent of animal tissue culture media and their specific applicationConstituent of animal tissue culture media and their specific application
Constituent of animal tissue culture media and their specific application
 
Animal Cloning Procedure, Problems and Perspectives
Animal Cloning Procedure, Problems and PerspectivesAnimal Cloning Procedure, Problems and Perspectives
Animal Cloning Procedure, Problems and Perspectives
 
BioPharming (Molecular Farming)
BioPharming (Molecular Farming)BioPharming (Molecular Farming)
BioPharming (Molecular Farming)
 
Recombinant protein-Factor VIII
Recombinant protein-Factor VIIIRecombinant protein-Factor VIII
Recombinant protein-Factor VIII
 
Transgenic animal production and its application
Transgenic animal  production and its applicationTransgenic animal  production and its application
Transgenic animal production and its application
 

Similar to Xenotransplantation

Sbi4 u xenotransplantation
Sbi4 u xenotransplantationSbi4 u xenotransplantation
Sbi4 u xenotransplantation
wellsjw
 
Aniket_An Integrated Approach to Biology
Aniket_An Integrated Approach to BiologyAniket_An Integrated Approach to Biology
Aniket_An Integrated Approach to Biology
Aniket Bhattacharya
 

Similar to Xenotransplantation (20)

Transgenesis by Dr.Ashwini J. Patel-Gujarat
Transgenesis by Dr.Ashwini J. Patel-GujaratTransgenesis by Dr.Ashwini J. Patel-Gujarat
Transgenesis by Dr.Ashwini J. Patel-Gujarat
 
Transgenic animals (1) panjab university
Transgenic animals (1) panjab universityTransgenic animals (1) panjab university
Transgenic animals (1) panjab university
 
Transplant immunity & Transplantation_sandhya
Transplant immunity & Transplantation_sandhyaTransplant immunity & Transplantation_sandhya
Transplant immunity & Transplantation_sandhya
 
Transgenic-pigs- trilok.pptx
Transgenic-pigs- trilok.pptxTransgenic-pigs- trilok.pptx
Transgenic-pigs- trilok.pptx
 
Genetic Evidence For Theories Of Human Dispersal
Genetic Evidence For Theories Of Human DispersalGenetic Evidence For Theories Of Human Dispersal
Genetic Evidence For Theories Of Human Dispersal
 
Xenotransplantation of pig kidney to human
Xenotransplantation of pig kidney to humanXenotransplantation of pig kidney to human
Xenotransplantation of pig kidney to human
 
Sbi4 u xenotransplantation
Sbi4 u xenotransplantationSbi4 u xenotransplantation
Sbi4 u xenotransplantation
 
Presentation final
Presentation finalPresentation final
Presentation final
 
Aniket_An Integrated Approach to Biology
Aniket_An Integrated Approach to BiologyAniket_An Integrated Approach to Biology
Aniket_An Integrated Approach to Biology
 
Cancer,oncogenes and Tumor suppressor genes
Cancer,oncogenes and Tumor suppressor genes Cancer,oncogenes and Tumor suppressor genes
Cancer,oncogenes and Tumor suppressor genes
 
12th origin and evolution of life.pdf
12th origin and evolution of life.pdf12th origin and evolution of life.pdf
12th origin and evolution of life.pdf
 
Toxoplasmose final
Toxoplasmose finalToxoplasmose final
Toxoplasmose final
 
Group-6Gene-Therapy-_20240402_150300_0000-1.pdf
Group-6Gene-Therapy-_20240402_150300_0000-1.pdfGroup-6Gene-Therapy-_20240402_150300_0000-1.pdf
Group-6Gene-Therapy-_20240402_150300_0000-1.pdf
 
Jc liver tumors
Jc liver tumorsJc liver tumors
Jc liver tumors
 
5.1 evidence for evolution
5.1 evidence for evolution5.1 evidence for evolution
5.1 evidence for evolution
 
Forensic Science
Forensic ScienceForensic Science
Forensic Science
 
Markers
MarkersMarkers
Markers
 
Transplantation Surgery
Transplantation Surgery Transplantation Surgery
Transplantation Surgery
 
Sunu 25.1.2
Sunu 25.1.2Sunu 25.1.2
Sunu 25.1.2
 
Sunu 25.1.2
Sunu 25.1.2Sunu 25.1.2
Sunu 25.1.2
 

More from khehkesha

Composition of food and proximate analysis
Composition of food and proximate analysisComposition of food and proximate analysis
Composition of food and proximate analysis
khehkesha
 
Fermented food
Fermented food Fermented food
Fermented food
khehkesha
 
Food born dieases or illness
Food born dieases or illness Food born dieases or illness
Food born dieases or illness
khehkesha
 
Phylum nematoda (1)
Phylum nematoda (1)Phylum nematoda (1)
Phylum nematoda (1)
khehkesha
 
Phylum echinodermata
Phylum echinodermata Phylum echinodermata
Phylum echinodermata
khehkesha
 
minisatellites
 minisatellites minisatellites
minisatellites
khehkesha
 
Scope of biotechnology
Scope of  biotechnologyScope of  biotechnology
Scope of biotechnology
khehkesha
 
Cancer immunotherapy
Cancer immunotherapyCancer immunotherapy
Cancer immunotherapy
khehkesha
 
Immunology presentation
Immunology presentationImmunology presentation
Immunology presentation
khehkesha
 
Fermentation presentation
Fermentation presentationFermentation presentation
Fermentation presentation
khehkesha
 
Liquid mixing
Liquid mixingLiquid mixing
Liquid mixing
khehkesha
 
myasthenia gravis
myasthenia gravismyasthenia gravis
myasthenia gravis
khehkesha
 
Nanofiltration&electrophoresis
Nanofiltration&electrophoresisNanofiltration&electrophoresis
Nanofiltration&electrophoresis
khehkesha
 
cancer immunotherapy
cancer immunotherapycancer immunotherapy
cancer immunotherapy
khehkesha
 
Airlift bioreactor ppt
Airlift bioreactor pptAirlift bioreactor ppt
Airlift bioreactor ppt
khehkesha
 

More from khehkesha (18)

Map
MapMap
Map
 
Composition of food and proximate analysis
Composition of food and proximate analysisComposition of food and proximate analysis
Composition of food and proximate analysis
 
Fermented food
Fermented food Fermented food
Fermented food
 
Food born dieases or illness
Food born dieases or illness Food born dieases or illness
Food born dieases or illness
 
Probiotics
Probiotics Probiotics
Probiotics
 
Phylum nematoda (1)
Phylum nematoda (1)Phylum nematoda (1)
Phylum nematoda (1)
 
Phylum echinodermata
Phylum echinodermata Phylum echinodermata
Phylum echinodermata
 
minisatellites
 minisatellites minisatellites
minisatellites
 
Scope of biotechnology
Scope of  biotechnologyScope of  biotechnology
Scope of biotechnology
 
Mammals
MammalsMammals
Mammals
 
Cancer immunotherapy
Cancer immunotherapyCancer immunotherapy
Cancer immunotherapy
 
Immunology presentation
Immunology presentationImmunology presentation
Immunology presentation
 
Fermentation presentation
Fermentation presentationFermentation presentation
Fermentation presentation
 
Liquid mixing
Liquid mixingLiquid mixing
Liquid mixing
 
myasthenia gravis
myasthenia gravismyasthenia gravis
myasthenia gravis
 
Nanofiltration&electrophoresis
Nanofiltration&electrophoresisNanofiltration&electrophoresis
Nanofiltration&electrophoresis
 
cancer immunotherapy
cancer immunotherapycancer immunotherapy
cancer immunotherapy
 
Airlift bioreactor ppt
Airlift bioreactor pptAirlift bioreactor ppt
Airlift bioreactor ppt
 

Xenotransplantation

  • 2. CONCEPT Xenotransplantation is the transplantation of cells, tissues or organs from one species to another, particularly transplants from animals to humans. It was formulated to overcome the shortage of donor organs.
  • 4.
  • 5. TYPES OF XENOTRANSPLANTATION SOLID ORGAN XENOTRA NSPLANT CELLULAR HUMAN/A /TISSUE NIMAL TYPES XENOTRA HYBRID NSPLANT EXTERNAL THERAPIES
  • 6. CHOOSING THE DONOR SPECIES TYPE BETWEEN EXAMPLE CONCORDANT Closely related/si Baboon Human milar species DISCORDANT Distantly related/ Pig Human dissimilar species
  • 7. TRANSPLANTATION REJECTION;IMMUNOLOGICAL BARRIERS 1.Hyperacute xenograft rejection,HXR 2.Cellular xenograft rejection, 3.Acute vascular xenograft rejection,ACXR 4.Chronic xenograft rejection,
  • 9. OVERCOMING HYPERACUTE REJECTION •alter the organ source through using genetically engineered pigs (e.g., pigs that will lack the α-Gal epitope and/or will have an artificially added gene[s] for human complement-regulatory proteins (such as decay-accelerating factor) • alter the recipient by depleting naturally occurring antibodies directed against α-Gal (NXAs) prior to xenograft receipt. Either approach to overcoming HAR may also facilitate the potential for the human recipient to be infected by endogenous retroviruses from the pig xenotransplantation product.
  • 10. 2.Acute vascular xenograft rejection,ACXR
  • 11. OVERCOMING ACUTE VASCULAR REJECTION •Administering a synthetic thrombin inhibitor to modulate thrombogenesis •Depletion of anti-galactose antibodies (XNAs) by techniques such as immunoadsorption, to prevent endothelial cell activation •Inhibiting activation of macrophages (stimulated by CD4+ T cells) and NK cells (stimulated by the release of Il-2). Thus, the role of MHC molecules and T cell responses in activation would have to be reassessed for each species combo.
  • 13. A proposed strategy to avoid cellular rejection is to induce donor non-responsiveness using hematopoietic chimerism. Donor stem cells are introduced into the bone marrow of the recipient, where they coexist with the recipient’s stem cells. The bone marrow stem cells give rise to cells of all hematopoietic lineages, through the process of hematopoiesis. Lymphoid progenitor cells are created by this process and move to the thymus where negative selection eliminates T cells found to be reactive to self. The existence of donor stem cells in the recipient’s bone marrow causes donor reactive T cells to be considered self and undergo apoptosis.
  • 15. One concern raised about xenotransplantation is the risk of inadvertent transmission of infectious agents into xenotransplant recipients and subsequent secondary transmission of infections to the wider human population. This risk is an important obstacle to the use of this technology. The potential for secondary transmission of infections makes the risk of xenozoonoses a global issue. XENOZOONOTIC DISEASE RISK AND PREVENTION ISSUES
  • 16. "O Adam! shall I lead thee to the Tree of Eternity and to a kingship that never decays?" (20:120). Satan also said "I will mislead them, and I will create in them false desires; I will order them to have (in abundance) the animals' ears cut (from the origin), and I will order them to change Allah's creation" (4:119).